Precision NanoSystems secures $7.8 mln in Series B round
Precision NanoSystems (PNI), a Vancouver-based developer of nanoparticles for use as medicines and in medical research, earlier this month raised about $7.8 million (US$6 million) in a Series B financing. The round was backed by 5AM Ventures, Telegraph Hill Partners and Rising Tide Fund, all of which backed the company's $13.4 million Series A financing in 2015. Founded in 2010 by CEO James Taylor and COO Euan Ramsay, PNI's NanoAssemblr platform enables the rapid, reproducible and scalable manufacture of nanoparticle formulations for the delivery of therapeutic and diagnostic agents to cells and tissues in the body. It will use the funds raised for new product development and global growth.
18 June 2018•3 mins read
